The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
PTEN: Multiple Functions in Human Malignant Tumors
Open accessAbstract
PTEN is the most important negative regulator of the PI3K signaling pathway. In addition to its canonical, PI3K inhibition-dependent functions, PTEN can also function as a tumor suppressor in a PI3K-independent manner. Indeed, the PTEN network regulates a broad spectrum of biological functions, modulating the flow of information from membrane-bound growth factor receptors to nuclear transcription factors, occurring in concert with other tumor suppressors and oncogenic signaling pathways. PTEN acts through its lipid and protein phosphatase activity and other non-enzymatic mechanisms. Studies conducted over the past 10 years have expanded our understanding of the biological role of PTEN, showing that in addition to its ability to regulate proliferation and cell survival, it also plays an intriguing role in regulating genomic stability, cell migration, stem cell self-renewal, and tumor microenvironment. Changes in PTEN protein levels, location, and enzymatic activity through various molecular mechanisms can generate a continuum of functional PTEN levels in inherited syndromes, sporadic cancers, and other diseases. PTEN activity can indeed, be modulated by mutations, epigenetic silencing, transcriptional repression, aberrant protein localization, and post-translational modifications. This review will discuss our current understanding of the biological role of PTEN, how PTEN expression and activity are regulated, and the consequences of PTEN dysregulation in human malignant tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chung, J.-H., Ginn-Pease, M. E., & Eng, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0124 · Cited by 164
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Nagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 1×
“show that, in addition to antagonizing HER2-driven tumorigenesis, PTEN also sensitizes breast cancer to trastuzumab treatment (37).”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
PTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
Reversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,057
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892
The PTEN–PI3K pathway: of feedbacks and cross-talks
Carracedo, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.247 · Cited by 878
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Palomero, T., Sulis, M. L., Cortina, M., Real, P. J., Barnes, K., Ciofani, M., Caparros, E., Buteau, J., Brown, K., Perkins, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1636 · Cited by 877
Polarization of Chemoattractant Receptor Signaling During Neutrophil Chemotaxis
Servant, G., Weiner, O. D., Herzmark, P., Balla, T., Sedat, J. W., & Bourne, H. R. (2000) · Science · doi:10.1126/science.287.5455.1037 · Cited by 877
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Loss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S., Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M., et al. (2006) · Nature · doi:10.1038/nature04747 · Cited by 817
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Alessi, D. R., Deak, M., Casamayor, A., Barry Caudwell, F., Morrice, N., Norman, D. G., Gaffney, P., Reese, C. B., MacDougall, C. N., Harbison, D., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00336-8 · Cited by 737
mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
Dowling, R. J. O., Topisirovic, I., Alain, T., Bidinosti, M., Fonseca, B. D., Petroulakis, E., Wang, X., Larsson, O., Selvaraj, A., Liu, Y., et al. (2010) · Science · doi:10.1126/science.1187532 · Cited by 726
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.039 · Cited by 720
Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, E., & Zhang, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702596104 · Cited by 698
Tumor Suppressor PTEN Mediates Sensing of Chemoattractant Gradients
Iijima, M., & Devreotes, P. (2002) · Cell · doi:10.1016/s0092-8674(02)00745-6 · Cited by 677
Pten Dose Dictates Cancer Progression in the Prostate
Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 676
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653 · cited 2×
“Patients with Cowden syndrome have a high risk for benign and malignant tumors of the breast (lifetime risk – LR-85%), thyroid (LR 35%), kidney (renal cell carcinoma – RCC-, LR 33%), and endometrium (LR 28%), which correspond to sporadic tumor types that commonly exhibit somatic PTEN inactivation (155, 157, 158) (Tabl…”
BackgroundDearden, S., Stevens, J., Wu, Y.-L., & Blowers, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt205 · Cited by 646
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Mendes‐Pereira, A. M., Martin, S. A., Brough, R., McCarthy, A., Taylor, J. R., Kim, J., Waldman, T., Lord, C. J., & Ashworth, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900041 · Cited by 638
The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus
Torres, J., & Pulido, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009134200 · Cited by 629
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Subtle variations in Pten dose determine cancer susceptibility
Alimonti, A., Carracedo, A., Clohessy, J. G., Trotman, L. C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W. J., Brogi, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.556 · Cited by 580
Zhang, J.-G., Wang, J.-J., Zhao, F., Liu, Q., Jiang, K., & Yang, G.-H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.074 · Cited by 563
DJ-1, a novel regulator of the tumor suppressor PTEN
Kim, R. H., Peters, M., Jang, Y., Shi, W., Pintilie, M., Fletcher, G. C., DeLuca, C., Liepa, J., Zhou, L., Snow, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.010 · Cited by 544
Saal, L. H., Johansson, P., Holm, K., Gruvberger-Saal, S. K., She, Q.-B., Maurer, M., Koujak, S., Ferrando, A. A., Malmström, P., Memeo, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702507104 · Cited by 520
Zhang, S., Huang, W.-C., Li, P., Guo, H., Poh, S.-B., Brady, S. W., Xiong, Y., Tseng, L.-M., Li, S.-H., Ding, Z., et al. (2011) · Nature Medicine · doi:10.1038/nm.2309 · Cited by 515
Freeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 515
Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas
Mu, P., Han, Y.-C., Betel, D., Yao, E., Squatrito, M., Ogrodowski, P., de Stanchina, E., D'Andrea, A., Sander, C., & Ventura, A. (2009) · Genes & Development · doi:10.1101/gad.1872909 · Cited by 452
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M. S., Hobbs, R. M., Sportoletti, P., Varmeh, S., Egia, A., Fedele, G., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000594 · Cited by 410
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria, J., Lee, H., Lee, J. I., Luo, W., Issa, J. J., Kemp, B. L., Liu, D. D., Kurie, J. M., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 406
Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress
Bassi, C., Ho, J., Srikumar, T., Dowling, R. J. O., Gorrini, C., Miller, S. J., Mak, T. W., Neel, B. G., Raught, B., & Stambolic, V. (2013) · Science · doi:10.1126/science.1236188 · Cited by 403
She, Q.-B., Halilovic, E., Ye, Q., Zhen, W., Shirasawa, S., Sasazuki, T., Solit, D. B., & Rosen, N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.023 · Cited by 400 · cited 1×
“Recently, 4EBP1 has indeed emerged as a key negative regulator of cell proliferation downstream of mTORC1, and its inactivation may directly promote the growth of sporadic cancers (190, 191).”
BackgroundWu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X.-J., Wood, J., Ross, C., Sawyers, C. L., & Whang, Y. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4233 · Cited by 400
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
Virolle, T., Adamson, E. D., Baron, V., Birle, D., Mercola, D., Mustelin, T., & de Belle, I. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1124 · Cited by 399
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Kim, J., Coffey, D. M., Creighton, C. J., Yu, Z., Hawkins, S. M., & Matzuk, M. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117135109 · Cited by 398
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
Steelman, L. S., Abrams, S. L., Whelan, J., Bertrand, F. E., Ludwig, D. E., Bäsecke, J., Libra, M., Stivala, F., Milella, M., Tafuri, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.26 · Cited by 385
Self-citationSystemic elevation of PTEN induces a tumor-suppressive metabolic state
Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C. J., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.030 · Cited by 377
Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner
Song, M. S., Carracedo, A., Salmena, L., Song, S. J., Egia, A., Malumbres, M., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2010.12.020 · Cited by 376
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
Durinck, S., Stawiski, E. W., Pavía-Jiménez, A., Modrusan, Z., Kapur, P., Jaiswal, B. S., Zhang, N., Toffessi-Tcheuyap, V., Nguyen, T. T., Pahuja, K. B., et al. (2015) · Nature Genetics · doi:10.1038/ng.3146 · Cited by 357
Pten positively regulates brown adipose function, energy expenditure, and longevity
Ortega-Molina, A., Efeyan, A., Lopez-Guadamillas, E., Muñoz-Martin, M., Gómez-López, G., Cañamero, M., Mulero, F., Pastor, J., Martinez, S., Romanos, E., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.001 · Cited by 356
Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN
Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., & Hall, A. (2004) · Science · doi:10.1126/science.1092089 · Cited by 335
Mutations of the human PTEN gene
Bonneau, D., & Longy, M. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<109::aid-humu3>3.0.co;2-0 · Cited by 333
Gimm, O., Perren, A., Weng, L.-P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65040-7 · Cited by 327
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Kwabi-Addo, B., Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N., & Ittmann, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201167798 · Cited by 323
A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival
Hopkins, B. D., Fine, B., Steinbach, N., Dendy, M., Rapp, Z., Shaw, J., Pappas, K., Yu, J. S., Hodakoski, C., Mense, S., et al. (2013) · Science · doi:10.1126/science.1234907 · Cited by 320
Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus
Del Bufalo, D., Ciuffreda, L., Trisciuoglio, D., Desideri, M., Cognetti, F., Zupi, G., & Milella, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2825 · Cited by 317
Self-citationThe Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells
Putz, U., Howitt, J., Doan, A., Goh, C.-P., Low, L.-H., Silke, J., & Tan, S.-S. (2012) · Science Signaling · doi:10.1126/scisignal.2003084 · Cited by 312
PTEN function: the long and the short of it
Hopkins, B. D., Hodakoski, C., Barrows, D., Mense, S. M., & Parsons, R. E. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.006 · Cited by 309 · cited 2×
“PTEN-Long is expressed in normal tissues such as the breast and brain, whereas its expression levels are lower in human breast tumors and mouse models of glioblastoma (7, 20, 118).”
BackgroundPTEN negatively regulates neural stem cell self-renewal by modulating G 0 -G 1 cell cycle entry
Groszer, M., Erickson, R., Scripture-Adams, D. D., Dougherty, J. D., Le Belle, J., Zack, J. A., Geschwind, D. H., Liu, X., Kornblum, H. I., & Wu, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509939103 · Cited by 306 · cited 1×
“Similarly, PTEN loss causes increased proliferation, de-differentiation, and progression toward prostatic intraepithelial neoplasia in prostate stem cells (30, 59, 168, 169).”
BackgroundSalvesen, H. B., MacDonald, N., Ryan, A., Jacobs, I. J., Lynch, E. D., Akslen, L. A., & Das, S. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s · Cited by 294
Planchon, S. M., Waite, K. A., & Eng, C. (2008) · Journal of Cell Science · doi:10.1242/jcs.022459 · Cited by 293
Rewired ERK-JNK Signaling Pathways in Melanoma
Lopez-Bergami, P., Huang, C., Goydos, J. S., Yip, D., Bar-Eli, M., Herlyn, M., Smalley, K. S. M., Mahale, A., Eroshkin, A., Aaronson, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.009 · Cited by 286
Epigenetic Silencing of the PTEN Gene in Melanoma
Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T., & Hengge, U. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0384 · Cited by 279
High-resolution characterization of the pancreatic adenocarcinoma genome
Aguirre, A. J., Brennan, C., Bailey, G., Sinha, R., Feng, B., Leo, C., Zhang, Y., Zhang, J., Gans, J. D., Bardeesy, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402932101 · Cited by 277
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Piovan, E., Yu, J., Tosello, V., Herranz, D., Ambesi-Impiombato, A., Da Silva, A. C., Sanchez-Martin, M., Perez-Garcia, A., Rigo, I., Castillo, M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.022 · Cited by 256
Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S., & Mustelin, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503045200 · Cited by 252
PTEN Level in Tumor Suppression: How Much Is Too Little?
Carracedo, A., Alimonti, A., & Pandolfi, P. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2488 · Cited by 246
Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN
Vivanco, I., Palaskas, N., Tran, C., Finn, S. P., Getz, G., Kennedy, N. J., Jiao, J., Rose, J., Xie, W., Loda, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.021 · Cited by 245
Marsit, C. J., Zheng, S., Aldape, K., Hinds, P. W., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.006 · Cited by 243
PTEN controls tumor-induced angiogenesis
Wen, S., Stolarov, J., Myers, M. P., Su, J. D., Wigler, M. H., Tonks, N. K., & Durden, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081063798 · Cited by 241
Liang, H., He, S., Yang, J., Jia, X., Wang, P., Chen, X., Zhang, Z., Zou, X., McNutt, M. A., Shen, W. H., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.023 · Cited by 236
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity
Pal, A., Barber, T. M., Van de Bunt, M., Rudge, S. A., Zhang, Q., Lachlan, K. L., Cooper, N. S., Linden, H., Levy, J. C., Wakelam, M. J. O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113966 · Cited by 234
Tamguney, T., & Stokoe, D. (2007) · Journal of Cell Science · doi:10.1242/jcs.015230 · Cited by 234
McEllin, B., Camacho, C. V., Mukherjee, B., Hahm, B., Tomimatsu, N., Bachoo, R. M., & Burma, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4295 · Cited by 231
A Role for Nuclear PTEN in Neuronal Differentiation
Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01404.2000 · Cited by 230
PTEN Signaling pathways in glioblastoma
Koul, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6954 · Cited by 228
Funamoto, S., Milan, K., Meili, R., & Firtel, R. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.4.795 · Cited by 228
Direct identification of PTEN phosphorylation sites
Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S., & Neel, B. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03274-x · Cited by 226
Okumura, K., Mendoza, M., Bachoo, R. M., DePinho, R. A., Cavenee, W. K., & Furnari, F. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605391200 · Cited by 224
Ying, H., Elpek, K. G., Vinjamoori, A., Zimmerman, S. M., Chu, G. C., Yan, H., Fletcher-Sananikone, E., Zhang, H., Liu, Y., Wang, W., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0031 · Cited by 223
Lombardo, Y., Scopelliti, A., Cammareri, P., Todaro, M., Iovino, F., Ricci–Vitiani, L., Gulotta, G., Dieli, F., de Maria, R., & Stassi, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.005 · Cited by 222 · cited 1×
“Moreover, in colon CSC, PTEN expression is also strikingly upregulated during differentiation and by stimuli that inhibit CSC growth and tumorigenic activity, such as such as BMP4 treatment or thymosin β4 targeting (11, 174, 175).”
BackgroundPTEN signaling in brain: neuropathology and tumorigenesis
Endersby, R., & Baker, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.239 · Cited by 222
Understanding PTEN regulation: PIP2, polarity and protein stability
Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., & Downes, C. P. (2008) · Oncogene · doi:10.1038/onc.2008.243 · Cited by 221
Emerling, B. M., Weinberg, F., Liu, J.-L., Mak, T. W., & Chandel, N. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706790105 · Cited by 217
Xing, F., Persaud, Y., Pratilas, C. A., Taylor, B. S., Janakiraman, M., She, Q.-B., Gallardo, H., Liu, C., Merghoub, T., Hefter, B., et al. (2012) · Oncogene · doi:10.1038/onc.2011.250 · Cited by 207
Molecular pathology of endometrial carcinoma
Matias‐Guiu, X., & Prat, J. (2013) · Histopathology · doi:10.1111/his.12053 · Cited by 203
Nathanson, K. L., Martin, A.-M., Wubbenhorst, B., Greshock, J., Letrero, R., D'Andrea, K., O'Day, S., Infante, J. R., Falchook, G. S., Arkenau, H.-T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0827 · Cited by 196
The Tumor Suppressor PTEN Negatively Regulates Insulin Signaling in 3T3-L1 Adipocytes
Nakashima, N., Sharma, P. M., Imamura, T., Bookstein, R., & Olefsky, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12889 · Cited by 194
Escrivà, M., Peiró, S., Herranz, N., Villagrasa, P., Dave, N., Montserrat-Sentís, B., Murray, S. A., Francí, C., Gridley, T., Virtanen, I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02061-07 · Cited by 191
Jin, G., Kim, M. J., Jeon, H.-S., Choi, J. E., Kim, D. S., Lee, E. B., Cha, S. I., Yoon, G. S., Kim, C. H., Jung, T. H., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.012 · Cited by 185
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration
Leslie, N. R., Yang, X., Downes, C. P., & Weijer, C. J. (2007) · Current Biology · doi:10.1016/j.cub.2006.12.026 · Cited by 184
PTEN Gene Alterations in Lymphoid Neoplasms
Sakai, A., Thieblemont, C., Wellmann, A., Jaffe, E. S., & Raffeld, M. (1998) · Blood · doi:10.1182/blood.v92.9.3410 · Cited by 174
Stambolic, V., & Woodgett, J. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.001 · Cited by 172
Baker, S. J. (2007) · Cell · doi:10.1016/j.cell.2006.12.023 · Cited by 171
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers
Yokomizo, A., Tindall, D. J., Drabkin, H., Gemmill, R., Franklin, W., Yang, P., Sugio, K., Smith, D. I., & Liu, W. (1998) · Oncogene · doi:10.1038/sj.onc.1201956 · Cited by 170
The mTOR Pathway: A New Target in Cancer Therapy
Ciuffreda, L., Di Sanza, C., Incani, U. C., & Milella, M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791517172 · Cited by 170
Self-citationAmodio, N., Scrima, M., Palaia, L., Salman, A. N., Quintiero, A., Franco, R., Botti, G., Pirozzi, P., Rocco, G., Rosa, N. D., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091075 · Cited by 170
Lu, J., Jeong, H., Kong, N., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005577 · Cited by 168 · cited 1×
“have demonstrated that the zincfinger transcription factor sal-like protein 4 (SALL4) represses PTEN transcription by recruiting an epigenetic repressor complex (Mi-2/NuRD) (138).”
BackgroundThe Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration
Dey, N., Crosswell, H. E., De, P., Parsons, R., Peng, Q., Su, J. D., & Durden, D. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1182 · Cited by 168
Breast Cancer — Loss of PTEN Predicts Resistance to Treatment
Pandolfi, P. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmcibr043143 · Cited by 167
Lindsay, Y. E., McCoull, D., Davidson, L., Leslie, N. R., Fairservice, A., Gray, A., Lucocq, J. M., & Downes, C. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.000133 · Cited by 166
Functions and Regulation of the PTEN Gene in Colorectal Cancer
Molinari, F., & Frattini, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2013.00326 · Cited by 162
Herman, G. E., Butter, E., Enrile, B., Pastore, M., Prior, T. W., & Sommer, A. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31619 · Cited by 160
c-Jun promotes cellular survival by suppression of PTEN
Hettinger, K., Vikhanskaya, F., Poh, M. K., Lee, M. K., de Belle, I., Zhang, J.-T., Reddy, S. A. G., & Sabapathy, K. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401946 · Cited by 159
Non-genomic loss of PTEN function in cancer: not in my genes
Leslie, N. R., & Foti, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.005 · Cited by 158
Park, M., Kim, M., Park, I., Kang, H., Yoo, H., Park, S. H., Rhee, C. H., Hong, S., & Lee, S. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80906-6 · Cited by 154
Friday, B. B., Yu, C., Dy, G. K., Smith, P. D., Wang, L., Thibodeau, S. N., & Adjei, A. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1430 · Cited by 146
PTEN, Stem Cells, and Cancer Stem Cells
Hill, R., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800071200 · Cited by 145
PTEN mutation, methylation and expression in breast cancer patients
Zhang, H., LIANG, F., Zhi-ling, J., Song, S., & Jiang, Z. (2013) · Oncology Letters · doi:10.3892/ol.2013.1331 · Cited by 142
Novel Protein Modification by Kynurenine in Human Lenses
Vazquez, S., Aquilina, J. A., Sheil, M. M., Truscott, R. J. W., & Jamie, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107529200 · Cited by 138
CREB Is a Novel Nuclear Target of PTEN Phosphatase
Gu, T., Zhang, Z., Wang, J., Guo, J., Shen, W. H., & Yin, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3399 · Cited by 135
Mehenni, H., Lin-Marq, N., Buchet-Poyau, K., Reymond, A., Collart, M. A., Picard, D., & Antonarakis, S. E. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi225 · Cited by 132
PTEN Interacts with Histone H1 and Controls Chromatin Condensation
Chen, Z., Zhu, M., Yang, J., Liang, H., He, J., He, S., Wang, P., Kang, X., McNutt, M. A., Yin, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.008 · Cited by 126
PTEN promoter is methylated in a proportion of invasive breast cancers
Khan, S., Kumagai, T., Vora, J., Bose, N., Sehgal, I., Koeffler, H. P., & Bose, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20447 · Cited by 125
Scarisbrick, J. J., Woolford, A. J. ‐., Russell‐Jones, R., & Whittaker, S. J. (2000) · Blood · doi:10.1182/blood.v95.9.2937.009k15_2937_2942 · Cited by 125
Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN
Ariga (2009) · International Journal of Oncology · doi:10.3892/ijo_00000451 · Cited by 117
Ginn‐Pease, M. E., & Eng, C. (2003) · PubMed · Cited by 116
Okumura, K., Zhao, M., DePinho, R. A., Furnari, F. B., & Cavenee, W. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409370102 · Cited by 115
Ciuffreda, L., Bufalo, D. D., Desideri, M., Sanza, C. D., Stoppacciaro, A., Ricciardi, M. R., Chiaretti, S., Tavolaro, S., Benassi, B., Bellacosa, A., et al. (2009) · Neoplasia · doi:10.1593/neo.09398 · Cited by 111
Self-citationEvidence of ultraviolet type mutations in xeroderma pigmentosum melanomas
Wang, Y., DiGiovanna, J. J., Stern, J. B., Hornyak, T. J., Raffeld, M. A., Khan, S. G., Oh, K., Hollander, M. C., Dennis, P. A., & Kraemer, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812401106 · Cited by 111
BRAF-mutations in non-small cell lung cancer
Brustugun, O. T., Khattak, A. M., Trømborg, A. K., Beigi, M., Beiske, K., Lund‐Iversen, M., & Helland, Å. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.01.023 · Cited by 110
Zmajkovicova, K., Jesenberger, V., Catalanotti, F., Baumgärtner, C., Reyes, G. X., & Baccarini, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.037 · Cited by 102
Laurent, P.-A., Séverin, S., Gratacap, M., & Payrastre, B. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.006 · Cited by 92
Pan, L., Lü, J., Wang, X., Han, L., Zhang, Y., Han, S., & Huang, B. (2007) · Cancer · doi:10.1002/cncr.22585 · Cited by 92
Terrien, E., Chaffotte, A. F., Lafage, M., Khan, Z., Prehaud, C. J. N., Cordier, F., Simenel, C., Delepierre, M., BUC, H. C., Lafon, M., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002941 · Cited by 92
PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development
Sun, Z., Huang, C., He, J., Lamb, K. L., Kang, X., Gu, T., Shen, W. H., & Yin, Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.030 · Cited by 90
Advancing Precision Medicine for Prostate Cancer Through Genomics
Roychowdhury, S., & Chinnaiyan, A. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3662 · Cited by 90
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 88
Self-citationPten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity
Wong, J. T., Kim, P. T. W., Peacock, J. W., Yau, T. Y., Mui, A., Chung, S. W., Sossi, V., Doudet, D. J., Green, D., Ruth, T. J., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0531-x · Cited by 86
CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression
Whelan, J. T., Forbes, S. L., & Bertrand, F. E. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3648 · Cited by 86
Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2α Phosphorylation Pathway
Mounir, Z., Krishnamoorthy, J., Robertson, G. P., Scheuner, D., Kaufman, R. J., Georgescu, M., & Koromilas, A. E. (2009) · Science Signaling · doi:10.1126/scisignal.2000389 · Cited by 84
The multiple layers of non-genetic regulation of PTEN tumour suppressor activity
Correia, N., Gírio, A., Antunes, I., Martins, L. R., & Barata, J. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.017 · Cited by 83
Cheong, J., Eom, J.-I., Maeng, H. M., Lee, S., Hahn, J. S., Ko, Y. W., & Min, Y. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04452.x · Cited by 81
Kinases, tails and more: Regulation of PTEN function by phosphorylation
Fragoso, R., & Barata, J. T. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.015 · Cited by 79
Schade, B., Rao, T., Dourdin, N., Lesurf, R., Hallett, M. T., Cardiff, R. D., & Muller, W. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018937 · Cited by 77
PTEN modulators: a patent review
Boosani, C. S., & Agrawal, D. K. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.768985 · Cited by 74
Naguib, A., Cooke, J. C., Happerfield, L. C., Kerr, L., Gay, L. J., Luben, R., Ball, R. Y., Mitrou, P. N., McTaggart, A., & Arends, M. J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-123 · Cited by 73
Polo-like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-induced Prostate Cancer Formation
Liu, X. S., Song, B., Elzey, B. D., Ratliff, T. L., Konieczny, S. F., Liang Cheng, C., Ahmad, N., & Liu, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.269050 · Cited by 73
Alterations of the MMAC1/PTEN Gene in Lymphoid Malignancies
Grønbæk, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E. M., & HOU-JENSEN, K. (1998) · Blood · doi:10.1182/blood.v91.11.4388 · Cited by 71
Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Analysis of PTEN deletions and mutations in multiple myeloma
Chang, H., Xiao, Q., Claudio, J. O., Zhuang, L., Patterson, B. J., & Stewart, A. K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.07.008 · Cited by 69
Vasudevan, K. M., Burikhanov, R., Goswami, A., & Rangnekar, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1827 · Cited by 65
Inoue-Narita, T., Hamada, K., Sasaki, T., Hatakeyama, S., Fujita, S., Kawahara, K., Sasaki, M., Kishimoto, H., Eguchi, S., Kojima, I., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0889 · Cited by 64
Ciuffreda, L., Sanza, C. D., Incani, U. C., Eramo, A., Desideri, M., Biagioni, F., Passeri, D., Falcone, I., Sette, G., Bergamo, P., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0844-1 · Cited by 63
Self-citationPTEN: A master regulator of neuronal structure, function, and plasticity
García‐Junco‐Clemente, P., & Golshani, P. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.28358 · Cited by 62
Hlobílková, A., Guldberg, P., Thullberg, M., Zeuthen, J., Lukas, J., & Bártek, J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4867 · Cited by 58
Vellai, T., McCulloch, D., Gems, D., & Kovács, A. (2006) · Genetics · doi:10.1534/genetics.106.061499 · Cited by 57
Hu, T., Wang, C., Huang, C., Chen, C., Hung, C., Chen, C., Wang, J., Lu, S., Lee, C., Changchien, C., et al. (2007) · Oncology Reports · doi:10.3892/or.18.6.1417 · Cited by 51
The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy
Malaney, P., Uversky, V. N., & Davé, V. (2013) · Molecular BioSystems · doi:10.1039/c3mb70267g · Cited by 50
Morani, F., Phadngam, S., Follo, C., Titone, R., Aimaretti, G., Galetto, A., Alabiso, O., & Isidoro, C. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0118 · Cited by 49
Frattini, M., Signoroni, S., Pilotti, S., Bertario, L., Benvenuti, S., Zanon, C., Bardelli, A., & Pierotti, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2780 · Cited by 47
Byron, S. A., Loch, D. C., Wellens, C. L., Wortmann, A., Wu, J., Wang, J., Nomoto, K., & Pollock, P. M. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-75 · Cited by 46
Thyroid tumorigenesis and molecular markers in thyroid cancer
Kouniavsky, G., & Zeiger, M. A. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328333846f · Cited by 39
Fabi, A., Metro, G., Benedetto, A. D., Nisticò, C., Vici, P., Melucci, E., Antoniani, B., Perracchio, L., Sperduti, I., Milella, M., et al. (2010) · Oncology · doi:10.1159/000312656 · Cited by 38
Self-citationTargeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells
Martelli, A. M., Lonetti, A., Buontempo, F., Ricci, F., Tazzari, P. L., Evangelisti, C., Bressanin, D., Cappellini, A., Orsini, E., & Chiarini, F. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.04.004 · Cited by 38
Razis, E. D., Pentheroudakis, G. E., Rigakos, G., Bobos, M., Kouvatseas, G., Tzaida, O., Makatsoris, T., Papakostas, P., Bai, M. C., GOUSSIA, A. C., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1626-2 · Cited by 37
Thymosin β4 targeting impairs tumorigenic activity of colon cancer stem cells
Ricci‐Vitiani, L., Mollinari, C., Martino, S. D., Biffoni, M., Pilozzi, E., Pagliuca, A., de Stefano, M. C., Circo, R., Merlo, D., Maria, R. D., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-159970 · Cited by 35
PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas
van Nederveen, F. H., Perren, A. A., Dannenberg, H., Petri, B., Dinjens, W. N. M., Komminoth, P., & de Krijger, R. R. (2006) · The Journal of Pathology · doi:10.1002/path.1968 · Cited by 32
Dellas, A., Jundt, G., Sartorius, G. A., Schneider, M., & Moch, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1732 · Cited by 30
Blind, R. D. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.015 · Cited by 29
Mester, J. L., Moore, R. A., & Eng, C. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0174 · Cited by 29
PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer
Cordes, I., Kluth, M., Zygis, D., Rink, M., Chun, F. K. ‐., Eichelberg, C., Dahlem, R., Fisch, M., Höppner, W., Wagner, W. P., et al. (2013) · Histopathology · doi:10.1111/his.12209 · Cited by 28
Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer
Chowdhury, S., Ongchin, M. C., Wan, G., Sharratt, E., Brattain, M. G., & Rajput, A. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.03.035 · Cited by 27
Predictive factors for response to treatment in patients with advanced renal cell carcinoma
López, C. M., Esteban, E., Astudillo, A., Pardo, P., Berros, J. P., Izquierdo, M. M., Crespo, G., Fonseca, P. J., Sanmamed, M. F., & Martínez‐Camblor, P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9836-4 · Cited by 21
PTEN Does Not Modulate GLUT4 Translocation in Rat Adipose Cells under Physiological Conditions
Mosser, V. A., Li, Y., & Quon, M. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5876 · Cited by 18
PTEN: An Intercellular Peacekeeper?
Leslie, N. R. (2012) · Science Signaling · doi:10.1126/scisignal.2003685 · Cited by 12
Purification and Properties of the Dictyostelium Calpain-like Protein, Cpl ,
Huang, X., Czerwinski, E. P., & Mellgren, R. L. (2003) · Biochemistry · doi:10.1021/bi026461+ · Cited by 12
PTEN in the haematopoietic system and its therapeutic indications
Cheung, A., & Mak, T. W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.002 · Cited by 10
Zhong, Y., Yan, J., Deng, M., Hu, K., Yao, Z., Zou, Y., & Xu, R. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213494654 · Cited by 4
Cited by
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian, T., Li, X., & Zhang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030755 · Cited by 576
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021) · Cancers · doi:10.3390/cancers13163949 · Cited by 497
Zhou, Y., Ren, H., Dai, B., Li, J., Shang, L., Huang, J., & Shi, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0965-2 · Cited by 456
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
Advances in studies of tyrosine kinase inhibitors and their acquired resistance
Jiao, Q., Bi, L., Ren, Y., Song, S., Wang, Q., & Wang, Y.-S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0801-5 · Cited by 395
Metadata
- Authors
- Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., & Ciuffreda, L.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2015-02-16
- Volume
- 5
- Pages
- 24-24
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2118263932
- Cited by
- 463
- References
- 194
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.